Quantum BioPharma's LUCID-MS program is built around the unmet need for MS therapies capable of directly protecting or ...
The growing burden of neurological disease has intensified industry-wide interest in therapies capable of protecting neurons, ...
View Quantum Biopharma Ltd. Subordinate Voting Shares Class B QNTM stock quote prices, financial information, real-time forecasts, and company news from CNN.
Shares of Quantum BioPharma Ltd. (NASDAQ:QNTM) soared more than 80% on Tuesday after the company announced positive clinical trial results for its dietary supplement, unbuzzd, which accelerates the ...
Shares of Quantum BioPharma (QNTM) surged 15% in pre-market trading on Monday after the biotech firm signed a binding agreement with Allucent to support a planned Phase 2 trial of its Lucid-MS therapy ...
Quantum BioPharma Ltd. (NASDAQ:QNTM) shares are surging Thursday after its licensee, Celly Nutrition, engaged a New York investment bank to raise up to $10 million and explore a potential U.S. initial ...
They’re all around us, hiding in plain sight. One could be in the room with you right now, just to your left. You could be seeing it this very second, but from one heartbeat to the next, you’ll forget ...
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. Quantum BioPharma’s LUCID-MS program is built around the unmet need for MS therapies capable of ...
This article has been disseminated on behalf of Quantum BioPharma Ltd. and may include paid advertising. The growing burden of neurological disease has intensified industry-wide interest in therapies ...